 Rachel Frank
Concepts (839)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroscopy | 58 | 2025 | 245 | 9.870 |
Why?
| | Shoulder Joint | 50 | 2024 | 177 | 9.440 |
Why?
| | Joint Instability | 36 | 2024 | 168 | 8.820 |
Why?
| | Cartilage, Articular | 22 | 2025 | 332 | 4.850 |
Why?
| | Knee Injuries | 18 | 2022 | 102 | 4.600 |
Why?
| | Knee Joint | 29 | 2025 | 412 | 4.530 |
Why?
| | Tibial Meniscus Injuries | 12 | 2025 | 49 | 4.520 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 16 | 2025 | 143 | 4.420 |
Why?
| | Biological Products | 12 | 2024 | 239 | 4.380 |
Why?
| | Shoulder Dislocation | 17 | 2026 | 53 | 4.330 |
Why?
| | Orthopedic Procedures | 19 | 2021 | 229 | 4.250 |
Why?
| | Tibia | 14 | 2025 | 181 | 4.190 |
Why?
| | Menisci, Tibial | 17 | 2025 | 63 | 4.030 |
Why?
| | Sports Medicine | 11 | 2026 | 117 | 3.750 |
Why?
| | Anterior Cruciate Ligament Injuries | 16 | 2025 | 162 | 3.600 |
Why?
| | Bone Transplantation | 14 | 2025 | 89 | 3.470 |
Why?
| | Athletic Injuries | 21 | 2025 | 525 | 3.410 |
Why?
| | Osteotomy | 12 | 2025 | 124 | 3.320 |
Why?
| | Platelet-Rich Plasma | 13 | 2025 | 36 | 3.220 |
Why?
| | Orthopedics | 12 | 2025 | 154 | 3.170 |
Why?
| | Osteoarthritis, Knee | 17 | 2025 | 270 | 2.950 |
Why?
| | Femoracetabular Impingement | 8 | 2018 | 35 | 2.880 |
Why?
| | Simulation Training | 6 | 2024 | 126 | 2.850 |
Why?
| | Rotator Cuff Injuries | 11 | 2023 | 62 | 2.500 |
Why?
| | Hip Joint | 8 | 2018 | 175 | 2.320 |
Why?
| | Tenodesis | 8 | 2020 | 21 | 2.320 |
Why?
| | Cartilage Diseases | 5 | 2019 | 45 | 2.280 |
Why?
| | Arthroplasty, Replacement, Knee | 9 | 2025 | 372 | 2.210 |
Why?
| | Arthroplasty | 10 | 2020 | 53 | 2.210 |
Why?
| | Reoperation | 29 | 2023 | 590 | 2.210 |
Why?
| | Meniscus | 4 | 2023 | 23 | 2.090 |
Why?
| | Allografts | 19 | 2025 | 147 | 2.010 |
Why?
| | Humans | 303 | 2026 | 140898 | 1.950 |
Why?
| | Shoulder Injuries | 9 | 2024 | 59 | 1.940 |
Why?
| | Shoulder | 22 | 2023 | 93 | 1.750 |
Why?
| | Return to Sport | 10 | 2025 | 96 | 1.720 |
Why?
| | Arthroplasty, Replacement, Shoulder | 9 | 2020 | 34 | 1.700 |
Why?
| | Cartilage | 10 | 2025 | 191 | 1.670 |
Why?
| | Transplantation, Homologous | 19 | 2025 | 415 | 1.650 |
Why?
| | Computer Simulation | 6 | 2021 | 1011 | 1.650 |
Why?
| | Sports | 7 | 2023 | 219 | 1.600 |
Why?
| | Tendons | 10 | 2020 | 123 | 1.550 |
Why?
| | Suture Anchors | 7 | 2021 | 34 | 1.510 |
Why?
| | Musculoskeletal Diseases | 5 | 2024 | 84 | 1.500 |
Why?
| | Clinical Competence | 8 | 2024 | 1196 | 1.490 |
Why?
| | Athletes | 7 | 2023 | 412 | 1.470 |
Why?
| | Scapula | 11 | 2023 | 44 | 1.470 |
Why?
| | Acromioclavicular Joint | 3 | 2023 | 11 | 1.460 |
Why?
| | Patient Reported Outcome Measures | 10 | 2025 | 437 | 1.390 |
Why?
| | Tendon Injuries | 5 | 2019 | 67 | 1.370 |
Why?
| | Postoperative Complications | 24 | 2022 | 2813 | 1.300 |
Why?
| | Adult | 128 | 2026 | 39134 | 1.260 |
Why?
| | Second-Look Surgery | 3 | 2025 | 7 | 1.200 |
Why?
| | Femur | 9 | 2025 | 260 | 1.180 |
Why?
| | Treatment Outcome | 50 | 2025 | 11125 | 1.150 |
Why?
| | Humeral Head | 7 | 2023 | 15 | 1.120 |
Why?
| | Young Adult | 50 | 2025 | 13646 | 1.120 |
Why?
| | Male | 160 | 2026 | 69893 | 1.110 |
Why?
| | Evidence-Based Medicine | 7 | 2020 | 712 | 1.110 |
Why?
| | Bankart Lesions | 4 | 2023 | 9 | 1.090 |
Why?
| | Arthroplasty, Subchondral | 4 | 2018 | 7 | 1.080 |
Why?
| | Rotator Cuff | 8 | 2023 | 47 | 1.050 |
Why?
| | Anterior Cruciate Ligament | 9 | 2023 | 81 | 1.050 |
Why?
| | Female | 156 | 2026 | 75540 | 1.040 |
Why?
| | Internship and Residency | 8 | 2024 | 1222 | 1.020 |
Why?
| | Middle Aged | 106 | 2026 | 34487 | 1.010 |
Why?
| | Bone Screws | 5 | 2020 | 105 | 1.010 |
Why?
| | Bone Malalignment | 2 | 2025 | 13 | 1.010 |
Why?
| | Joint Dislocations | 2 | 2024 | 51 | 0.990 |
Why?
| | Female Athlete Triad Syndrome | 2 | 2017 | 8 | 0.990 |
Why?
| | Ligaments, Articular | 5 | 2023 | 54 | 0.980 |
Why?
| | Education, Medical, Graduate | 5 | 2019 | 523 | 0.970 |
Why?
| | Hemiarthroplasty | 3 | 2020 | 9 | 0.960 |
Why?
| | Osteoarthritis | 7 | 2019 | 203 | 0.930 |
Why?
| | Range of Motion, Articular | 17 | 2023 | 413 | 0.930 |
Why?
| | Orthopedic Surgeons | 2 | 2023 | 27 | 0.910 |
Why?
| | Achilles Tendon | 2 | 2023 | 31 | 0.880 |
Why?
| | Follow-Up Studies | 37 | 2021 | 5194 | 0.860 |
Why?
| | Biomechanical Phenomena | 16 | 2023 | 837 | 0.830 |
Why?
| | Quadriceps Muscle | 2 | 2023 | 118 | 0.820 |
Why?
| | Blood Loss, Surgical | 2 | 2014 | 112 | 0.820 |
Why?
| | Cadaver | 13 | 2020 | 301 | 0.810 |
Why?
| | Adolescent | 75 | 2025 | 22027 | 0.790 |
Why?
| | Brain Concussion | 5 | 2025 | 588 | 0.770 |
Why?
| | Social Media | 2 | 2024 | 159 | 0.770 |
Why?
| | Venous Thrombosis | 2 | 2022 | 192 | 0.740 |
Why?
| | Retrospective Studies | 57 | 2025 | 16315 | 0.730 |
Why?
| | Lacerations | 1 | 2022 | 40 | 0.720 |
Why?
| | Pain | 6 | 2018 | 776 | 0.710 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2014 | 187 | 0.700 |
Why?
| | Golf | 1 | 2020 | 8 | 0.660 |
Why?
| | Bone Resorption | 3 | 2018 | 84 | 0.660 |
Why?
| | Rupture | 8 | 2023 | 88 | 0.660 |
Why?
| | Skiing | 1 | 2021 | 51 | 0.650 |
Why?
| | Radiography | 16 | 2019 | 844 | 0.650 |
Why?
| | Hypertension | 12 | 2025 | 1251 | 0.650 |
Why?
| | Suture Techniques | 8 | 2019 | 128 | 0.630 |
Why?
| | Hamstring Muscles | 2 | 2018 | 21 | 0.620 |
Why?
| | Internet | 3 | 2022 | 682 | 0.610 |
Why?
| | Aged | 72 | 2025 | 24666 | 0.610 |
Why?
| | Physical Examination | 9 | 2018 | 242 | 0.600 |
Why?
| | Humerus | 7 | 2020 | 41 | 0.590 |
Why?
| | Kidney Transplantation | 6 | 2024 | 677 | 0.570 |
Why?
| | Tenotomy | 1 | 2018 | 19 | 0.560 |
Why?
| | Swimming | 1 | 2018 | 50 | 0.560 |
Why?
| | Prosthesis Failure | 5 | 2015 | 125 | 0.560 |
Why?
| | Virtual Reality | 1 | 2019 | 74 | 0.550 |
Why?
| | Yoga | 1 | 2018 | 30 | 0.550 |
Why?
| | Glenoid Cavity | 2 | 2015 | 7 | 0.540 |
Why?
| | Adipose Tissue | 6 | 2025 | 645 | 0.540 |
Why?
| | Carcinoma, Renal Cell | 4 | 2019 | 221 | 0.540 |
Why?
| | Meniscectomy | 3 | 2025 | 16 | 0.540 |
Why?
| | Treatment Failure | 6 | 2020 | 353 | 0.540 |
Why?
| | Facial Recognition | 1 | 2018 | 35 | 0.540 |
Why?
| | Leg Injuries | 1 | 2017 | 25 | 0.540 |
Why?
| | Imaging, Three-Dimensional | 4 | 2018 | 566 | 0.530 |
Why?
| | Bone Density | 2 | 2021 | 495 | 0.530 |
Why?
| | Facial Expression | 1 | 2018 | 77 | 0.530 |
Why?
| | Fractures, Stress | 1 | 2017 | 33 | 0.530 |
Why?
| | Venous Thromboembolism | 1 | 2022 | 336 | 0.530 |
Why?
| | Bundle of His | 1 | 2017 | 18 | 0.520 |
Why?
| | Stress, Mechanical | 3 | 2019 | 488 | 0.520 |
Why?
| | Olecranon Process | 1 | 2017 | 7 | 0.520 |
Why?
| | Fractures, Ununited | 1 | 2017 | 26 | 0.510 |
Why?
| | Prosthesis-Related Infections | 2 | 2015 | 98 | 0.510 |
Why?
| | Muscle, Skeletal | 8 | 2020 | 1750 | 0.510 |
Why?
| | Cumulative Trauma Disorders | 1 | 2017 | 31 | 0.510 |
Why?
| | Ulna Fractures | 1 | 2017 | 16 | 0.510 |
Why?
| | Bicycling | 1 | 2017 | 117 | 0.510 |
Why?
| | Social Perception | 1 | 2018 | 105 | 0.510 |
Why?
| | Open Fracture Reduction | 1 | 2017 | 31 | 0.510 |
Why?
| | Hip | 3 | 2014 | 57 | 0.510 |
Why?
| | Injections, Intra-Articular | 9 | 2025 | 59 | 0.510 |
Why?
| | Mesenchymal Stem Cell Transplantation | 3 | 2025 | 59 | 0.510 |
Why?
| | Atrioventricular Block | 1 | 2017 | 37 | 0.500 |
Why?
| | Chondrocytes | 2 | 2018 | 228 | 0.500 |
Why?
| | Databases, Factual | 10 | 2019 | 1441 | 0.490 |
Why?
| | Osteosarcoma | 2 | 2015 | 72 | 0.480 |
Why?
| | Incidence | 13 | 2025 | 2782 | 0.480 |
Why?
| | Kidney Neoplasms | 4 | 2019 | 400 | 0.470 |
Why?
| | Soft Tissue Injuries | 1 | 2016 | 34 | 0.470 |
Why?
| | Patellar Ligament | 2 | 2014 | 25 | 0.470 |
Why?
| | Stereotyping | 1 | 2015 | 43 | 0.460 |
Why?
| | Electrocardiography | 5 | 2017 | 617 | 0.460 |
Why?
| | Transplantation, Autologous | 6 | 2023 | 280 | 0.460 |
Why?
| | Prejudice | 1 | 2015 | 60 | 0.450 |
Why?
| | Bone-Patellar Tendon-Bone Grafts | 1 | 2014 | 2 | 0.450 |
Why?
| | Comprehension | 2 | 2014 | 182 | 0.450 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 5 | 2023 | 68 | 0.440 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2017 | 141 | 0.440 |
Why?
| | Cohort Studies | 14 | 2023 | 5789 | 0.440 |
Why?
| | Ilium | 1 | 2014 | 29 | 0.440 |
Why?
| | Fracture Fixation, Internal | 1 | 2017 | 200 | 0.430 |
Why?
| | Arthroplasty, Replacement | 5 | 2016 | 46 | 0.430 |
Why?
| | Patient Education as Topic | 4 | 2024 | 772 | 0.430 |
Why?
| | Hip Injuries | 1 | 2014 | 15 | 0.430 |
Why?
| | Blood Pressure | 9 | 2025 | 1745 | 0.430 |
Why?
| | Child | 51 | 2025 | 22313 | 0.420 |
Why?
| | Patellofemoral Joint | 2 | 2023 | 8 | 0.420 |
Why?
| | Retroperitoneal Neoplasms | 2 | 2013 | 21 | 0.420 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2014 | 771 | 0.410 |
Why?
| | Hip Prosthesis | 1 | 2014 | 46 | 0.410 |
Why?
| | Materials Testing | 2 | 2017 | 353 | 0.410 |
Why?
| | Patient Satisfaction | 3 | 2018 | 690 | 0.400 |
Why?
| | Body Mass Index | 6 | 2025 | 2374 | 0.400 |
Why?
| | Computer-Assisted Instruction | 1 | 2013 | 68 | 0.400 |
Why?
| | Graft Survival | 6 | 2019 | 501 | 0.400 |
Why?
| | Models, Educational | 1 | 2013 | 95 | 0.400 |
Why?
| | Time-to-Treatment | 1 | 2015 | 223 | 0.400 |
Why?
| | Delphi Technique | 9 | 2025 | 313 | 0.400 |
Why?
| | Bone and Bones | 1 | 2016 | 313 | 0.390 |
Why?
| | Liposarcoma | 1 | 2013 | 26 | 0.390 |
Why?
| | Models, Anatomic | 1 | 2013 | 86 | 0.390 |
Why?
| | Recurrence | 15 | 2023 | 1104 | 0.390 |
Why?
| | Education, Medical, Continuing | 1 | 2013 | 128 | 0.380 |
Why?
| | Risk Factors | 24 | 2024 | 10430 | 0.380 |
Why?
| | Postoperative Period | 8 | 2019 | 360 | 0.380 |
Why?
| | Pain Measurement | 9 | 2025 | 552 | 0.380 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2013 | 59 | 0.380 |
Why?
| | Emotions | 1 | 2018 | 575 | 0.380 |
Why?
| | Femur Neck | 1 | 2012 | 63 | 0.380 |
Why?
| | Femur Head | 1 | 2012 | 41 | 0.380 |
Why?
| | Pain Management | 2 | 2014 | 395 | 0.370 |
Why?
| | Autism Spectrum Disorder | 1 | 2018 | 418 | 0.370 |
Why?
| | Ozone | 3 | 2001 | 133 | 0.370 |
Why?
| | Acetabulum | 2 | 2014 | 110 | 0.370 |
Why?
| | Nephrectomy | 2 | 2013 | 156 | 0.370 |
Why?
| | Universities | 1 | 2014 | 449 | 0.360 |
Why?
| | Musculoskeletal System | 2 | 2022 | 49 | 0.350 |
Why?
| | Magnetic Resonance Imaging | 6 | 2025 | 3724 | 0.350 |
Why?
| | Rotation | 3 | 2018 | 121 | 0.350 |
Why?
| | Hyaluronic Acid | 7 | 2025 | 230 | 0.350 |
Why?
| | Surveys and Questionnaires | 9 | 2026 | 5931 | 0.350 |
Why?
| | Age Factors | 11 | 2019 | 3278 | 0.340 |
Why?
| | Nephrotic Syndrome | 4 | 2022 | 38 | 0.340 |
Why?
| | Tomography, X-Ray Computed | 9 | 2020 | 2760 | 0.330 |
Why?
| | Activities of Daily Living | 4 | 2018 | 425 | 0.330 |
Why?
| | Football | 3 | 2017 | 89 | 0.320 |
Why?
| | United States | 22 | 2025 | 15195 | 0.320 |
Why?
| | Stem Cell Transplantation | 3 | 2020 | 187 | 0.310 |
Why?
| | Aged, 80 and over | 22 | 2021 | 7899 | 0.310 |
Why?
| | Joint Prosthesis | 3 | 2015 | 21 | 0.310 |
Why?
| | Random Allocation | 4 | 2019 | 363 | 0.310 |
Why?
| | Reproducibility of Results | 9 | 2024 | 3336 | 0.310 |
Why?
| | Health Care Surveys | 3 | 2017 | 562 | 0.300 |
Why?
| | Pilot Projects | 7 | 2021 | 1815 | 0.290 |
Why?
| | Hypertrophy, Left Ventricular | 3 | 2023 | 119 | 0.290 |
Why?
| | Sex Factors | 6 | 2019 | 2051 | 0.290 |
Why?
| | Physical Therapy Modalities | 3 | 2023 | 318 | 0.280 |
Why?
| | Patient Readmission | 3 | 2018 | 707 | 0.270 |
Why?
| | Mass Screening | 2 | 2014 | 1300 | 0.260 |
Why?
| | Joint Diseases | 3 | 2019 | 61 | 0.260 |
Why?
| | Nephrology | 2 | 2024 | 61 | 0.260 |
Why?
| | Glomerulosclerosis, Focal Segmental | 4 | 2016 | 45 | 0.250 |
Why?
| | Ambulatory Surgical Procedures | 2 | 2017 | 75 | 0.250 |
Why?
| | Risk Assessment | 9 | 2025 | 3484 | 0.250 |
Why?
| | Arthralgia | 2 | 2025 | 57 | 0.250 |
Why?
| | Patient Positioning | 2 | 2019 | 70 | 0.240 |
Why?
| | Infant Mortality | 2 | 2004 | 121 | 0.240 |
Why?
| | Synovectomy | 1 | 2025 | 8 | 0.240 |
Why?
| | Matched-Pair Analysis | 2 | 2016 | 38 | 0.230 |
Why?
| | Synovitis | 1 | 2025 | 36 | 0.230 |
Why?
| | Video Recording | 2 | 2024 | 197 | 0.230 |
Why?
| | Head Injuries, Closed | 1 | 2025 | 49 | 0.230 |
Why?
| | Electrocoagulation | 4 | 2014 | 35 | 0.230 |
Why?
| | Pulmonary Embolism | 3 | 2018 | 238 | 0.230 |
Why?
| | Soccer | 1 | 2025 | 42 | 0.220 |
Why?
| | Wound Healing | 3 | 2013 | 350 | 0.220 |
Why?
| | Complement Activation | 2 | 2025 | 415 | 0.220 |
Why?
| | Humeral Fractures | 2 | 2017 | 46 | 0.220 |
Why?
| | Tachycardia, Ventricular | 4 | 2000 | 175 | 0.220 |
Why?
| | Viscosupplements | 3 | 2020 | 11 | 0.220 |
Why?
| | Catheter Ablation | 5 | 2000 | 313 | 0.220 |
Why?
| | Time Factors | 18 | 2019 | 6944 | 0.220 |
Why?
| | Complement Factor H | 1 | 2025 | 79 | 0.220 |
Why?
| | Clinical Trials as Topic | 2 | 2020 | 1031 | 0.210 |
Why?
| | Synovial Membrane | 1 | 2025 | 121 | 0.210 |
Why?
| | Reading | 3 | 2014 | 135 | 0.210 |
Why?
| | Patellar Dislocation | 1 | 2023 | 6 | 0.210 |
Why?
| | Caffeine | 1 | 2024 | 74 | 0.210 |
Why?
| | Curriculum | 2 | 2021 | 1029 | 0.210 |
Why?
| | Prognosis | 13 | 2020 | 4060 | 0.210 |
Why?
| | Bone Marrow | 3 | 2023 | 301 | 0.210 |
Why?
| | Prehypertension | 1 | 2023 | 27 | 0.210 |
Why?
| | Practice Patterns, Physicians' | 3 | 2026 | 1328 | 0.210 |
Why?
| | Prospective Studies | 10 | 2023 | 7749 | 0.200 |
Why?
| | Consensus | 5 | 2025 | 545 | 0.200 |
Why?
| | Heart Ventricles | 5 | 2019 | 749 | 0.200 |
Why?
| | Cross-Sectional Studies | 10 | 2026 | 5645 | 0.200 |
Why?
| | Sutures | 3 | 2019 | 60 | 0.200 |
Why?
| | Urolithiasis | 2 | 2016 | 10 | 0.190 |
Why?
| | Debridement | 4 | 2017 | 88 | 0.190 |
Why?
| | Ankle Injuries | 1 | 2023 | 64 | 0.190 |
Why?
| | Recovery of Function | 7 | 2019 | 680 | 0.190 |
Why?
| | Postoperative Care | 4 | 2019 | 280 | 0.190 |
Why?
| | Research Design | 2 | 2018 | 1104 | 0.180 |
Why?
| | Intra-Articular Fractures | 2 | 2019 | 19 | 0.180 |
Why?
| | Oxidants, Photochemical | 1 | 2001 | 8 | 0.180 |
Why?
| | Urinary Diversion | 2 | 1998 | 13 | 0.170 |
Why?
| | Preoperative Period | 2 | 2018 | 143 | 0.170 |
Why?
| | Cardiovascular Diseases | 2 | 2024 | 2082 | 0.170 |
Why?
| | Verbal Learning | 2 | 2007 | 65 | 0.170 |
Why?
| | Osteoarthritis, Hip | 1 | 2021 | 48 | 0.170 |
Why?
| | Knee Dislocation | 1 | 2021 | 7 | 0.170 |
Why?
| | Biology | 1 | 2022 | 92 | 0.170 |
Why?
| | Arm | 2 | 2019 | 108 | 0.170 |
Why?
| | Ankle | 2 | 2019 | 61 | 0.170 |
Why?
| | Drug Chronotherapy | 1 | 2020 | 1 | 0.170 |
Why?
| | Comorbidity | 5 | 2018 | 1658 | 0.170 |
Why?
| | Arthritis, Rheumatoid | 4 | 2025 | 1178 | 0.170 |
Why?
| | Operating Rooms | 2 | 2024 | 146 | 0.170 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2025 | 1598 | 0.170 |
Why?
| | Socioeconomic Factors | 2 | 2004 | 1310 | 0.160 |
Why?
| | Echocardiography | 4 | 2020 | 648 | 0.160 |
Why?
| | Arrhythmogenic Right Ventricular Dysplasia | 1 | 2000 | 57 | 0.160 |
Why?
| | Antihypertensive Agents | 2 | 2020 | 507 | 0.160 |
Why?
| | Direct-to-Consumer Advertising | 1 | 2020 | 7 | 0.160 |
Why?
| | Marketing of Health Services | 1 | 2020 | 15 | 0.160 |
Why?
| | Multiple Trauma | 1 | 2021 | 113 | 0.160 |
Why?
| | Autografts | 2 | 2023 | 50 | 0.160 |
Why?
| | Delayed Graft Function | 2 | 2018 | 33 | 0.160 |
Why?
| | Absorptiometry, Photon | 1 | 2021 | 265 | 0.160 |
Why?
| | Algorithms | 3 | 2023 | 1763 | 0.160 |
Why?
| | Osteonecrosis | 1 | 2020 | 24 | 0.160 |
Why?
| | Kidney | 7 | 2016 | 1475 | 0.160 |
Why?
| | Spinal Neoplasms | 1 | 2019 | 36 | 0.150 |
Why?
| | Intraoperative Complications | 2 | 2012 | 147 | 0.150 |
Why?
| | Artificial Intelligence | 1 | 2023 | 332 | 0.150 |
Why?
| | Bone Substitutes | 1 | 2019 | 27 | 0.150 |
Why?
| | Kidney Diseases | 3 | 2024 | 408 | 0.150 |
Why?
| | Tensile Strength | 1 | 2019 | 96 | 0.150 |
Why?
| | Workers' Compensation | 1 | 2019 | 27 | 0.150 |
Why?
| | Graft Rejection | 3 | 2018 | 546 | 0.150 |
Why?
| | Pudendal Nerve | 1 | 2018 | 2 | 0.140 |
Why?
| | Shoulder Impingement Syndrome | 2 | 2018 | 7 | 0.140 |
Why?
| | Surgeons | 1 | 2023 | 335 | 0.140 |
Why?
| | Acromion | 2 | 2017 | 8 | 0.140 |
Why?
| | Visual Analog Scale | 1 | 2018 | 35 | 0.140 |
Why?
| | Odds Ratio | 2 | 2018 | 1054 | 0.140 |
Why?
| | Osteochondritis Dissecans | 1 | 2018 | 10 | 0.140 |
Why?
| | Thinness | 1 | 2018 | 95 | 0.140 |
Why?
| | Prosthesis Design | 3 | 2015 | 338 | 0.140 |
Why?
| | Mycophenolic Acid | 3 | 2008 | 118 | 0.140 |
Why?
| | Immunosuppressive Agents | 3 | 2008 | 854 | 0.140 |
Why?
| | Urinary Bladder Diseases | 1 | 1998 | 18 | 0.140 |
Why?
| | Radius | 1 | 2018 | 51 | 0.140 |
Why?
| | Arthrography | 1 | 2017 | 19 | 0.140 |
Why?
| | Ambulatory Care Facilities | 1 | 2020 | 246 | 0.140 |
Why?
| | Spine | 1 | 2019 | 180 | 0.140 |
Why?
| | Bone Marrow Transplantation | 1 | 2019 | 293 | 0.140 |
Why?
| | Child, Preschool | 19 | 2025 | 11462 | 0.130 |
Why?
| | Attitude of Health Personnel | 1 | 2026 | 1175 | 0.130 |
Why?
| | Sleep Wake Disorders | 1 | 2021 | 304 | 0.130 |
Why?
| | Length of Stay | 3 | 2018 | 1259 | 0.130 |
Why?
| | Hospital Charges | 1 | 2017 | 44 | 0.130 |
Why?
| | Surgical Wound Infection | 3 | 2018 | 321 | 0.130 |
Why?
| | Multiple Sclerosis | 3 | 2008 | 468 | 0.130 |
Why?
| | Bronchi | 2 | 1996 | 267 | 0.130 |
Why?
| | Anticoagulants | 1 | 2022 | 674 | 0.130 |
Why?
| | Nephrons | 1 | 2016 | 22 | 0.130 |
Why?
| | Hypercalciuria | 1 | 2016 | 2 | 0.130 |
Why?
| | Orthopedic Fixation Devices | 1 | 2016 | 8 | 0.120 |
Why?
| | Dementia | 1 | 2000 | 262 | 0.120 |
Why?
| | Fever | 2 | 2017 | 308 | 0.120 |
Why?
| | Shoulder Fractures | 1 | 2016 | 14 | 0.120 |
Why?
| | Medical History Taking | 2 | 2014 | 117 | 0.120 |
Why?
| | Patient Safety | 1 | 2020 | 334 | 0.120 |
Why?
| | Emergency Medical Services | 1 | 2023 | 650 | 0.120 |
Why?
| | Elbow Joint | 1 | 2016 | 75 | 0.120 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2018 | 274 | 0.120 |
Why?
| | Minimally Invasive Surgical Procedures | 3 | 2014 | 180 | 0.120 |
Why?
| | Diagnosis, Differential | 4 | 2018 | 1491 | 0.120 |
Why?
| | Femoral Neck Fractures | 1 | 2015 | 22 | 0.120 |
Why?
| | Glomerular Filtration Rate | 6 | 2020 | 752 | 0.120 |
Why?
| | Case-Control Studies | 3 | 2019 | 3578 | 0.120 |
Why?
| | Femoral Neoplasms | 1 | 2015 | 9 | 0.110 |
Why?
| | Tendinopathy | 1 | 2015 | 28 | 0.110 |
Why?
| | Lung Diseases | 2 | 2001 | 793 | 0.110 |
Why?
| | Respiratory Mechanics | 1 | 1995 | 72 | 0.110 |
Why?
| | Kidney Failure, Chronic | 3 | 2018 | 599 | 0.110 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 348 | 0.110 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2014 | 11 | 0.110 |
Why?
| | Limb Salvage | 1 | 2015 | 65 | 0.110 |
Why?
| | Ontario | 3 | 2023 | 95 | 0.110 |
Why?
| | Military Personnel | 2 | 2020 | 615 | 0.110 |
Why?
| | Hemodilution | 1 | 2014 | 11 | 0.110 |
Why?
| | Journal Impact Factor | 1 | 2014 | 26 | 0.110 |
Why?
| | Menstrual Cycle | 1 | 1995 | 134 | 0.110 |
Why?
| | Fracture Fixation | 1 | 2015 | 84 | 0.110 |
Why?
| | Tachycardia | 4 | 1989 | 55 | 0.110 |
Why?
| | Arthritis | 2 | 2016 | 104 | 0.110 |
Why?
| | Hemostasis, Surgical | 1 | 2014 | 27 | 0.110 |
Why?
| | Spinal Stenosis | 1 | 2014 | 31 | 0.110 |
Why?
| | Tourniquets | 1 | 2014 | 32 | 0.110 |
Why?
| | Running | 1 | 2016 | 232 | 0.110 |
Why?
| | Intervertebral Disc Displacement | 1 | 2014 | 41 | 0.100 |
Why?
| | Professional Practice | 1 | 2014 | 62 | 0.100 |
Why?
| | Laser Coagulation | 1 | 2014 | 71 | 0.100 |
Why?
| | Diagnostic Imaging | 2 | 2014 | 326 | 0.100 |
Why?
| | Prostheses and Implants | 1 | 2015 | 143 | 0.100 |
Why?
| | Hemostatics | 1 | 2014 | 58 | 0.100 |
Why?
| | Electromyography | 1 | 2016 | 411 | 0.100 |
Why?
| | Malnutrition | 1 | 2015 | 84 | 0.100 |
Why?
| | Pressure | 1 | 2014 | 228 | 0.100 |
Why?
| | Prosthesis Implantation | 1 | 2015 | 156 | 0.100 |
Why?
| | Blood Component Transfusion | 1 | 2014 | 97 | 0.100 |
Why?
| | Arrhythmias, Cardiac | 5 | 2001 | 337 | 0.100 |
Why?
| | Nutrition Surveys | 2 | 2025 | 280 | 0.100 |
Why?
| | Circadian Rhythm | 2 | 2016 | 509 | 0.100 |
Why?
| | Canada | 1 | 2014 | 419 | 0.100 |
Why?
| | Learning Curve | 1 | 2013 | 70 | 0.100 |
Why?
| | Adrenal Cortex Hormones | 2 | 2015 | 501 | 0.100 |
Why?
| | Patient Selection | 3 | 2025 | 684 | 0.100 |
Why?
| | Athletic Performance | 1 | 2014 | 81 | 0.100 |
Why?
| | Health Status Disparities | 1 | 2016 | 297 | 0.100 |
Why?
| | Societies, Medical | 2 | 2014 | 852 | 0.100 |
Why?
| | Metals | 1 | 2014 | 140 | 0.100 |
Why?
| | Gait | 1 | 2016 | 315 | 0.100 |
Why?
| | Multivariate Analysis | 5 | 2017 | 1496 | 0.100 |
Why?
| | Arthrometry, Articular | 1 | 2012 | 8 | 0.090 |
Why?
| | Incidental Findings | 1 | 2013 | 79 | 0.090 |
Why?
| | Popliteal Vein | 1 | 2012 | 4 | 0.090 |
Why?
| | Watchful Waiting | 1 | 2012 | 85 | 0.090 |
Why?
| | Pneumonia | 1 | 2018 | 656 | 0.090 |
Why?
| | Posterior Cruciate Ligament | 1 | 2012 | 13 | 0.090 |
Why?
| | Ultrasonography | 3 | 2022 | 760 | 0.090 |
Why?
| | Nutritional Status | 1 | 2015 | 357 | 0.090 |
Why?
| | Locomotion | 1 | 2012 | 106 | 0.090 |
Why?
| | Periodicals as Topic | 1 | 2014 | 197 | 0.090 |
Why?
| | Registries | 2 | 2018 | 2143 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1643 | 0.090 |
Why?
| | Circumcision, Male | 1 | 2011 | 16 | 0.090 |
Why?
| | Popliteal Artery | 1 | 2012 | 62 | 0.090 |
Why?
| | Educational Measurement | 1 | 2014 | 315 | 0.090 |
Why?
| | Diagnostic Errors | 1 | 2012 | 174 | 0.090 |
Why?
| | Prednisone | 3 | 2007 | 228 | 0.090 |
Why?
| | Osseointegration | 1 | 2012 | 71 | 0.090 |
Why?
| | Policy Making | 1 | 2011 | 79 | 0.090 |
Why?
| | Proteinuria | 3 | 2007 | 99 | 0.090 |
Why?
| | Smoking | 1 | 2018 | 1573 | 0.080 |
Why?
| | Sexual Behavior | 1 | 2015 | 493 | 0.080 |
Why?
| | Tooth | 2 | 1990 | 45 | 0.080 |
Why?
| | Disability Evaluation | 1 | 2012 | 303 | 0.080 |
Why?
| | Ankle Joint | 2 | 2023 | 115 | 0.080 |
Why?
| | Interleukin-7 | 1 | 2010 | 62 | 0.080 |
Why?
| | Reference Standards | 1 | 2010 | 185 | 0.080 |
Why?
| | Preventive Health Services | 1 | 2011 | 154 | 0.080 |
Why?
| | Bicuspid | 2 | 1988 | 16 | 0.080 |
Why?
| | Upper Extremity | 1 | 2010 | 109 | 0.080 |
Why?
| | Lead | 1 | 1990 | 71 | 0.080 |
Why?
| | Molar | 2 | 1988 | 48 | 0.080 |
Why?
| | Cancer Vaccines | 1 | 2010 | 166 | 0.080 |
Why?
| | Referral and Consultation | 2 | 2012 | 794 | 0.070 |
Why?
| | Biopsy, Needle | 1 | 2009 | 187 | 0.070 |
Why?
| | Fractures, Bone | 1 | 2014 | 406 | 0.070 |
Why?
| | Transplant Recipients | 2 | 2022 | 181 | 0.070 |
Why?
| | Naturopathy | 1 | 2008 | 2 | 0.070 |
Why?
| | Vascular Surgical Procedures | 1 | 2012 | 333 | 0.070 |
Why?
| | Pesticide Residues | 1 | 1988 | 4 | 0.070 |
Why?
| | Sepsis | 1 | 2015 | 620 | 0.070 |
Why?
| | Transillumination | 1 | 1988 | 3 | 0.070 |
Why?
| | Mexico | 2 | 2004 | 229 | 0.070 |
Why?
| | Urologic Diseases | 1 | 2008 | 40 | 0.070 |
Why?
| | Urography | 2 | 1998 | 19 | 0.070 |
Why?
| | Spirometry | 2 | 2001 | 260 | 0.070 |
Why?
| | Neuropsychological Tests | 2 | 2019 | 1089 | 0.070 |
Why?
| | Rheumatoid Factor | 3 | 2025 | 177 | 0.070 |
Why?
| | Insecticides | 1 | 1988 | 41 | 0.070 |
Why?
| | Quality Improvement | 1 | 2016 | 1234 | 0.070 |
Why?
| | Heart Arrest | 2 | 2012 | 384 | 0.070 |
Why?
| | Glomerulonephritis, Membranous | 1 | 2007 | 2 | 0.070 |
Why?
| | Leptospira interrogans | 2 | 1985 | 4 | 0.070 |
Why?
| | Systole | 2 | 2019 | 175 | 0.070 |
Why?
| | Diagnostic Tests, Routine | 1 | 2008 | 110 | 0.070 |
Why?
| | Ginkgo biloba | 1 | 2007 | 9 | 0.070 |
Why?
| | Hospitalization | 3 | 2016 | 2261 | 0.070 |
Why?
| | Dental Caries | 2 | 1988 | 173 | 0.070 |
Why?
| | Creatinine | 3 | 2008 | 490 | 0.060 |
Why?
| | Severity of Illness Index | 5 | 2016 | 2898 | 0.060 |
Why?
| | Logistic Models | 3 | 2015 | 2088 | 0.060 |
Why?
| | HLA-DR Antigens | 2 | 1997 | 227 | 0.060 |
Why?
| | Lysholm Knee Score | 2 | 2016 | 8 | 0.060 |
Why?
| | Reagent Strips | 1 | 2006 | 8 | 0.060 |
Why?
| | Milk, Human | 1 | 1988 | 169 | 0.060 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2001 | 649 | 0.060 |
Why?
| | Fatigue | 1 | 2008 | 338 | 0.060 |
Why?
| | Depressive Disorder | 2 | 2006 | 374 | 0.060 |
Why?
| | Minimal Clinically Important Difference | 1 | 2025 | 24 | 0.060 |
Why?
| | Urine | 1 | 2006 | 62 | 0.060 |
Why?
| | Dental Enamel | 3 | 1990 | 68 | 0.060 |
Why?
| | Nephrosis, Lipoid | 1 | 2005 | 10 | 0.060 |
Why?
| | Ligaments | 2 | 2020 | 74 | 0.060 |
Why?
| | Obesity | 1 | 2018 | 3000 | 0.060 |
Why?
| | Return to Work | 2 | 2015 | 19 | 0.060 |
Why?
| | Hyperparathyroidism | 1 | 2004 | 11 | 0.060 |
Why?
| | Plant Extracts | 1 | 2007 | 210 | 0.060 |
Why?
| | Sleep | 2 | 2022 | 879 | 0.060 |
Why?
| | Shoulder Pain | 2 | 2018 | 32 | 0.060 |
Why?
| | Lung | 2 | 1995 | 4127 | 0.050 |
Why?
| | History, 21st Century | 1 | 2025 | 218 | 0.050 |
Why?
| | Leukocytes | 1 | 2006 | 306 | 0.050 |
Why?
| | Probability | 2 | 2006 | 308 | 0.050 |
Why?
| | Regression Analysis | 4 | 2016 | 1015 | 0.050 |
Why?
| | Maternal Age | 1 | 2004 | 128 | 0.050 |
Why?
| | Weil Disease | 1 | 1983 | 1 | 0.050 |
Why?
| | Acidosis, Renal Tubular | 1 | 2003 | 4 | 0.050 |
Why?
| | Cognition Disorders | 1 | 2008 | 513 | 0.050 |
Why?
| | Joint Capsule | 2 | 2016 | 10 | 0.050 |
Why?
| | Peripheral Nerve Injuries | 2 | 2017 | 38 | 0.050 |
Why?
| | Parathyroid Hormone | 1 | 2004 | 111 | 0.050 |
Why?
| | Failure to Thrive | 1 | 2003 | 29 | 0.050 |
Why?
| | Health Status | 2 | 2008 | 820 | 0.050 |
Why?
| | Radionuclide Angiography | 2 | 2001 | 3 | 0.050 |
Why?
| | Bicarbonates | 1 | 2003 | 45 | 0.050 |
Why?
| | Social Justice | 1 | 2004 | 84 | 0.050 |
Why?
| | Felodipine | 1 | 2003 | 4 | 0.050 |
Why?
| | Vesico-Ureteral Reflux | 1 | 2003 | 35 | 0.050 |
Why?
| | Blood Chemical Analysis | 1 | 2003 | 110 | 0.050 |
Why?
| | Antibodies, Bacterial | 1 | 1983 | 145 | 0.050 |
Why?
| | Immobilization | 1 | 2023 | 46 | 0.050 |
Why?
| | Urinalysis | 2 | 2016 | 77 | 0.050 |
Why?
| | Tissue Scaffolds | 1 | 2025 | 213 | 0.050 |
Why?
| | Injections | 1 | 2023 | 191 | 0.050 |
Why?
| | Evaluation Studies as Topic | 3 | 1998 | 172 | 0.050 |
Why?
| | Leukocyte Count | 1 | 2023 | 328 | 0.050 |
Why?
| | Receptors, Cholecystokinin | 1 | 2002 | 9 | 0.050 |
Why?
| | Indoleacetic Acids | 1 | 2002 | 10 | 0.050 |
Why?
| | Dyslipidemias | 1 | 2024 | 175 | 0.050 |
Why?
| | Hormone Antagonists | 1 | 2002 | 34 | 0.050 |
Why?
| | Tomography, Emission-Computed | 1 | 2002 | 68 | 0.050 |
Why?
| | Nephritis, Hereditary | 1 | 2002 | 3 | 0.050 |
Why?
| | Enalapril | 1 | 2002 | 16 | 0.050 |
Why?
| | American Heart Association | 1 | 2023 | 296 | 0.050 |
Why?
| | Environmental Exposure | 2 | 2001 | 578 | 0.050 |
Why?
| | Thiazoles | 1 | 2002 | 134 | 0.050 |
Why?
| | Emergencies | 1 | 2023 | 179 | 0.050 |
Why?
| | Infant | 8 | 2013 | 9790 | 0.050 |
Why?
| | Forecasting | 1 | 2023 | 383 | 0.050 |
Why?
| | Nitrites | 1 | 2002 | 88 | 0.050 |
Why?
| | Vaccines, Conjugate | 1 | 2002 | 63 | 0.040 |
Why?
| | Airway Resistance | 1 | 2001 | 40 | 0.040 |
Why?
| | Radiopharmaceuticals | 1 | 2002 | 188 | 0.040 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2002 | 147 | 0.040 |
Why?
| | Analysis of Variance | 4 | 2011 | 1313 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2016 | 328 | 0.040 |
Why?
| | Meningococcal Vaccines | 1 | 2002 | 64 | 0.040 |
Why?
| | Weight-Bearing | 2 | 2013 | 173 | 0.040 |
Why?
| | Dentin | 2 | 1990 | 21 | 0.040 |
Why?
| | Sensitivity and Specificity | 3 | 2018 | 1968 | 0.040 |
Why?
| | Urinary Tract Infections | 1 | 2003 | 193 | 0.040 |
Why?
| | Albuminuria | 1 | 2002 | 185 | 0.040 |
Why?
| | Respiration | 1 | 2001 | 210 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 197 | 0.040 |
Why?
| | Bartter Syndrome | 1 | 2000 | 8 | 0.040 |
Why?
| | Heart Function Tests | 1 | 2000 | 56 | 0.040 |
Why?
| | Antibiotic Prophylaxis | 1 | 2002 | 122 | 0.040 |
Why?
| | Pneumococcal Vaccines | 1 | 2002 | 138 | 0.040 |
Why?
| | Heart Diseases | 1 | 2004 | 334 | 0.040 |
Why?
| | Renal Artery Obstruction | 1 | 2000 | 28 | 0.040 |
Why?
| | Poverty | 1 | 2004 | 527 | 0.040 |
Why?
| | Renal Artery | 1 | 2000 | 40 | 0.040 |
Why?
| | Mental Status Schedule | 1 | 2000 | 34 | 0.040 |
Why?
| | Language Tests | 1 | 2000 | 23 | 0.040 |
Why?
| | Cognition | 2 | 2007 | 1220 | 0.040 |
Why?
| | Consumer Product Safety | 1 | 2020 | 30 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2001 | 2062 | 0.040 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 1999 | 27 | 0.040 |
Why?
| | HIV Infections | 2 | 2011 | 2967 | 0.040 |
Why?
| | Bacterial Infections | 1 | 2002 | 245 | 0.040 |
Why?
| | Seizures | 1 | 2023 | 439 | 0.040 |
Why?
| | Aggrecans | 1 | 2019 | 15 | 0.040 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2003 | 266 | 0.040 |
Why?
| | Pediatrics | 2 | 2024 | 1097 | 0.040 |
Why?
| | Quality of Life | 2 | 2015 | 3005 | 0.040 |
Why?
| | Survival Rate | 2 | 2001 | 1962 | 0.040 |
Why?
| | Vitamin E | 1 | 1999 | 123 | 0.040 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 195 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2002 | 498 | 0.040 |
Why?
| | Chronic Traumatic Encephalopathy | 1 | 2019 | 17 | 0.040 |
Why?
| | United Kingdom | 1 | 2020 | 319 | 0.040 |
Why?
| | Diastole | 1 | 2019 | 142 | 0.040 |
Why?
| | Proteoglycans | 1 | 2019 | 109 | 0.040 |
Why?
| | Urinary Bladder | 2 | 1998 | 195 | 0.040 |
Why?
| | Serum | 1 | 2019 | 58 | 0.040 |
Why?
| | Research Subjects | 1 | 2018 | 42 | 0.040 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1999 | 123 | 0.040 |
Why?
| | Depression | 1 | 2008 | 1487 | 0.040 |
Why?
| | Calcium | 1 | 2004 | 1190 | 0.040 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2001 | 243 | 0.030 |
Why?
| | ROC Curve | 1 | 2000 | 589 | 0.030 |
Why?
| | Thigh | 1 | 2018 | 48 | 0.030 |
Why?
| | Deltoid Muscle | 1 | 2017 | 6 | 0.030 |
Why?
| | Benzophenones | 1 | 2017 | 16 | 0.030 |
Why?
| | Cystoscopy | 1 | 1998 | 21 | 0.030 |
Why?
| | Pectoralis Muscles | 1 | 2017 | 20 | 0.030 |
Why?
| | Radiographic Image Enhancement | 1 | 1998 | 57 | 0.030 |
Why?
| | Anatomic Landmarks | 1 | 2017 | 30 | 0.030 |
Why?
| | Sciatic Nerve | 1 | 2018 | 63 | 0.030 |
Why?
| | Demography | 1 | 2018 | 295 | 0.030 |
Why?
| | Dissection | 1 | 2018 | 55 | 0.030 |
Why?
| | HLA-DP Antigens | 1 | 1997 | 33 | 0.030 |
Why?
| | Torque | 1 | 2017 | 80 | 0.030 |
Why?
| | Brachial Plexus | 1 | 2017 | 33 | 0.030 |
Why?
| | Biomarkers | 3 | 2019 | 4175 | 0.030 |
Why?
| | Ketones | 1 | 2017 | 51 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2025 | 2822 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2000 | 1261 | 0.030 |
Why?
| | White Coat Hypertension | 1 | 2016 | 4 | 0.030 |
Why?
| | Glucose | 1 | 2002 | 1031 | 0.030 |
Why?
| | Tarsal Bones | 1 | 2016 | 15 | 0.030 |
Why?
| | Adaptation, Psychological | 1 | 2022 | 678 | 0.030 |
Why?
| | User-Computer Interface | 1 | 1998 | 163 | 0.030 |
Why?
| | HLA-DQ Antigens | 1 | 1997 | 178 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2019 | 268 | 0.030 |
Why?
| | Respiratory Function Tests | 2 | 1996 | 560 | 0.030 |
Why?
| | Neuroimaging | 1 | 2019 | 279 | 0.030 |
Why?
| | Hominidae | 1 | 1997 | 85 | 0.030 |
Why?
| | Inspiratory Capacity | 1 | 1996 | 3 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1811 | 0.030 |
Why?
| | Atmosphere Exposure Chambers | 1 | 1995 | 7 | 0.030 |
Why?
| | Tissue Donors | 1 | 2019 | 405 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2024 | 1218 | 0.030 |
Why?
| | Frontal Lobe | 1 | 1997 | 161 | 0.030 |
Why?
| | Lung Volume Measurements | 1 | 1995 | 46 | 0.030 |
Why?
| | Antioxidants | 1 | 1999 | 596 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2016 | 145 | 0.030 |
Why?
| | Hemodynamics | 1 | 2000 | 1100 | 0.030 |
Why?
| | Synovitis, Pigmented Villonodular | 1 | 2015 | 3 | 0.030 |
Why?
| | Adenocarcinoma | 1 | 2002 | 895 | 0.030 |
Why?
| | Blood Glucose | 1 | 2025 | 2273 | 0.030 |
Why?
| | Ossification, Heterotopic | 1 | 2015 | 15 | 0.030 |
Why?
| | Endoscopy | 1 | 1998 | 323 | 0.030 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 1995 | 147 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2004 | 6257 | 0.030 |
Why?
| | Contraindications | 1 | 2015 | 85 | 0.030 |
Why?
| | Capillary Permeability | 1 | 1995 | 148 | 0.030 |
Why?
| | Pulmonary Ventilation | 1 | 1995 | 83 | 0.030 |
Why?
| | Dental Pulp | 1 | 1974 | 4 | 0.030 |
Why?
| | Remission, Spontaneous | 1 | 2014 | 40 | 0.030 |
Why?
| | Essential Hypertension | 1 | 2014 | 3 | 0.030 |
Why?
| | Radiotherapy Dosage | 1 | 2015 | 280 | 0.030 |
Why?
| | Vital Capacity | 1 | 1995 | 306 | 0.030 |
Why?
| | Nutrition Assessment | 1 | 2015 | 92 | 0.030 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 1995 | 141 | 0.030 |
Why?
| | Bronchoscopy | 1 | 1995 | 225 | 0.030 |
Why?
| | Wolff-Parkinson-White Syndrome | 1 | 1994 | 19 | 0.030 |
Why?
| | Insurance, Health | 2 | 2014 | 298 | 0.030 |
Why?
| | Periodontitis | 1 | 1974 | 53 | 0.030 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 119 | 0.030 |
Why?
| | Forced Expiratory Volume | 1 | 1995 | 484 | 0.030 |
Why?
| | Linear Models | 1 | 2016 | 854 | 0.030 |
Why?
| | Private Practice | 1 | 2014 | 20 | 0.030 |
Why?
| | Caregivers | 1 | 2022 | 940 | 0.030 |
Why?
| | Bibliometrics | 1 | 2014 | 59 | 0.030 |
Why?
| | Pancreatic Neoplasms | 1 | 2002 | 889 | 0.030 |
Why?
| | Urban Population | 2 | 1990 | 481 | 0.030 |
Why?
| | Guided Tissue Regeneration | 1 | 2013 | 13 | 0.030 |
Why?
| | Educational Status | 2 | 2013 | 462 | 0.030 |
Why?
| | Pregnancy | 2 | 2004 | 7035 | 0.030 |
Why?
| | Biopsy | 3 | 2007 | 1069 | 0.030 |
Why?
| | Polymers | 1 | 2017 | 493 | 0.030 |
Why?
| | Outpatients | 1 | 2017 | 418 | 0.030 |
Why?
| | Penile Diseases | 1 | 1993 | 4 | 0.030 |
Why?
| | Histoplasmosis | 1 | 1993 | 15 | 0.030 |
Why?
| | Electric Stimulation Therapy | 1 | 1994 | 81 | 0.020 |
Why?
| | Acute Disease | 3 | 2015 | 1010 | 0.020 |
Why?
| | Academies and Institutes | 1 | 2013 | 54 | 0.020 |
Why?
| | Survival Analysis | 1 | 2016 | 1320 | 0.020 |
Why?
| | Cervical Vertebrae | 1 | 2014 | 146 | 0.020 |
Why?
| | Biological Evolution | 1 | 1997 | 486 | 0.020 |
Why?
| | Inpatients | 1 | 2017 | 512 | 0.020 |
Why?
| | Polyethylene Glycols | 1 | 2017 | 639 | 0.020 |
Why?
| | Sarcoma | 1 | 2015 | 184 | 0.020 |
Why?
| | France | 2 | 1990 | 38 | 0.020 |
Why?
| | Pulmonary Edema | 2 | 2012 | 114 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 1995 | 517 | 0.020 |
Why?
| | Exercise Test | 1 | 1995 | 623 | 0.020 |
Why?
| | Bone Neoplasms | 1 | 2015 | 247 | 0.020 |
Why?
| | North America | 1 | 2013 | 305 | 0.020 |
Why?
| | Sterilization | 1 | 2012 | 24 | 0.020 |
Why?
| | Personal Health Services | 1 | 1991 | 1 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1038 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2013 | 389 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1536 | 0.020 |
Why?
| | Papua New Guinea | 1 | 2011 | 9 | 0.020 |
Why?
| | Intestinal Obstruction | 2 | 1991 | 53 | 0.020 |
Why?
| | Gamma Rays | 1 | 2012 | 57 | 0.020 |
Why?
| | Health Planning Guidelines | 1 | 2011 | 24 | 0.020 |
Why?
| | Medicare | 1 | 2017 | 806 | 0.020 |
Why?
| | Temporomandibular Joint | 1 | 1991 | 10 | 0.020 |
Why?
| | Denture, Complete | 1 | 1991 | 7 | 0.020 |
Why?
| | Mouth, Edentulous | 1 | 1991 | 10 | 0.020 |
Why?
| | Dentition | 1 | 1991 | 16 | 0.020 |
Why?
| | World Health Organization | 1 | 2011 | 103 | 0.020 |
Why?
| | Joint Capsule Release | 1 | 2011 | 2 | 0.020 |
Why?
| | Animals | 6 | 2019 | 37579 | 0.020 |
Why?
| | Mental Disorders | 1 | 2000 | 1123 | 0.020 |
Why?
| | Rhabdomyosarcoma | 1 | 1991 | 62 | 0.020 |
Why?
| | Health Literacy | 1 | 2013 | 176 | 0.020 |
Why?
| | B7-1 Antigen | 1 | 2010 | 57 | 0.020 |
Why?
| | Retinoids | 1 | 1990 | 34 | 0.020 |
Why?
| | Hospital Mortality | 1 | 2015 | 923 | 0.020 |
Why?
| | Rabbits | 1 | 2012 | 754 | 0.020 |
Why?
| | Epidemiologic Methods | 2 | 1988 | 94 | 0.020 |
Why?
| | Guanylate Cyclase | 1 | 1990 | 38 | 0.020 |
Why?
| | Polyethylene | 1 | 2010 | 17 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1999 | 1786 | 0.020 |
Why?
| | Intestine, Small | 1 | 1991 | 157 | 0.020 |
Why?
| | Models, Animal | 1 | 2012 | 393 | 0.020 |
Why?
| | Substance Abuse, Intravenous | 1 | 1991 | 122 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2024 | 2524 | 0.020 |
Why?
| | Bone Diseases | 1 | 1990 | 66 | 0.020 |
Why?
| | Health Services Needs and Demand | 1 | 2011 | 282 | 0.020 |
Why?
| | HLA Antigens | 1 | 2010 | 234 | 0.020 |
Why?
| | New York | 1 | 2009 | 127 | 0.020 |
Why?
| | Equipment Failure | 1 | 2009 | 111 | 0.020 |
Why?
| | Blood Urea Nitrogen | 1 | 2008 | 54 | 0.020 |
Why?
| | Fourier Analysis | 2 | 2001 | 40 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1093 | 0.020 |
Why?
| | Health Services Research | 1 | 2011 | 402 | 0.020 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1989 | 112 | 0.020 |
Why?
| | DDT | 1 | 1988 | 2 | 0.020 |
Why?
| | Polychlorinated Biphenyls | 1 | 1988 | 12 | 0.020 |
Why?
| | Transfection | 1 | 2010 | 936 | 0.020 |
Why?
| | Tooth, Deciduous | 1 | 1988 | 19 | 0.020 |
Why?
| | Health Policy | 1 | 2011 | 380 | 0.020 |
Why?
| | Population Surveillance | 1 | 2011 | 479 | 0.020 |
Why?
| | Preoperative Care | 1 | 2010 | 372 | 0.020 |
Why?
| | Hyperlipidemias | 1 | 2008 | 125 | 0.020 |
Why?
| | Michigan | 2 | 1985 | 131 | 0.020 |
Why?
| | Capsules | 1 | 2007 | 40 | 0.020 |
Why?
| | Lithotripsy | 1 | 2007 | 46 | 0.020 |
Why?
| | HLA-DRB1 Chains | 2 | 1997 | 111 | 0.020 |
Why?
| | Reference Values | 2 | 2000 | 803 | 0.020 |
Why?
| | Placebos | 1 | 2007 | 195 | 0.020 |
Why?
| | Public Health | 1 | 2011 | 554 | 0.020 |
Why?
| | Phytotherapy | 1 | 2007 | 82 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2007 | 114 | 0.020 |
Why?
| | Rodent Control | 1 | 1985 | 2 | 0.010 |
Why?
| | Angiography | 2 | 2000 | 207 | 0.010 |
Why?
| | Leptospirosis | 1 | 1985 | 8 | 0.010 |
Why?
| | Cardiomyopathies | 1 | 1989 | 331 | 0.010 |
Why?
| | Tooth Diseases | 1 | 1985 | 13 | 0.010 |
Why?
| | Cytokines | 1 | 2013 | 2092 | 0.010 |
Why?
| | Tooth Extraction | 1 | 1985 | 28 | 0.010 |
Why?
| | Amiodarone | 1 | 1985 | 27 | 0.010 |
Why?
| | Blood Gas Analysis | 2 | 2003 | 82 | 0.010 |
Why?
| | Benzofurans | 1 | 1985 | 25 | 0.010 |
Why?
| | Rural Population | 1 | 1990 | 605 | 0.010 |
Why?
| | Memory | 1 | 2007 | 263 | 0.010 |
Why?
| | Attitude to Health | 1 | 2008 | 451 | 0.010 |
Why?
| | Alleles | 2 | 1997 | 883 | 0.010 |
Why?
| | Inflammation | 1 | 1995 | 2891 | 0.010 |
Why?
| | Suburban Population | 1 | 1983 | 18 | 0.010 |
Why?
| | Hematocrit | 1 | 2004 | 104 | 0.010 |
Why?
| | Serum Albumin | 1 | 2004 | 152 | 0.010 |
Why?
| | Self Concept | 1 | 2006 | 259 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2008 | 2056 | 0.010 |
Why?
| | Exercise | 1 | 1995 | 2108 | 0.010 |
Why?
| | Occupational Diseases | 1 | 1985 | 160 | 0.010 |
Why?
| | Decision Making | 1 | 2011 | 950 | 0.010 |
Why?
| | Attention | 1 | 2007 | 454 | 0.010 |
Why?
| | Bronchopneumonia | 2 | 1973 | 6 | 0.010 |
Why?
| | Coronary Disease | 1 | 1985 | 370 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 3487 | 0.010 |
Why?
| | Learning | 1 | 2007 | 434 | 0.010 |
Why?
| | Wounds and Injuries | 1 | 2010 | 896 | 0.010 |
Why?
| | Delayed-Action Preparations | 1 | 2003 | 175 | 0.010 |
Why?
| | Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2002 | 13 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2010 | 2003 | 0.010 |
Why?
| | Technetium | 1 | 2001 | 9 | 0.010 |
Why?
| | Likelihood Functions | 1 | 2001 | 145 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2004 | 533 | 0.010 |
Why?
| | Ifosfamide | 1 | 1999 | 38 | 0.010 |
Why?
| | Death, Sudden, Cardiac | 1 | 2001 | 191 | 0.010 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 1999 | 89 | 0.010 |
Why?
| | Carboplatin | 1 | 1999 | 145 | 0.010 |
Why?
| | Etoposide | 1 | 1999 | 163 | 0.010 |
Why?
| | Collagen | 2 | 1991 | 460 | 0.010 |
Why?
| | Combined Modality Therapy | 2 | 1994 | 1240 | 0.010 |
Why?
| | Cause of Death | 1 | 2000 | 441 | 0.010 |
Why?
| | Stroke Volume | 1 | 2001 | 590 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 1999 | 713 | 0.010 |
Why?
| | HLA-DQ beta-Chains | 1 | 1997 | 62 | 0.010 |
Why?
| | Histocompatibility Testing | 1 | 1997 | 123 | 0.010 |
Why?
| | Prevalence | 1 | 2004 | 2780 | 0.010 |
Why?
| | Animals, Zoo | 1 | 1997 | 15 | 0.010 |
Why?
| | Hylobates | 1 | 1997 | 8 | 0.010 |
Why?
| | Pongo pygmaeus | 1 | 1997 | 7 | 0.010 |
Why?
| | Gorilla gorilla | 1 | 1997 | 18 | 0.010 |
Why?
| | Ileum | 1 | 1998 | 112 | 0.010 |
Why?
| | HLA-DP beta-Chains | 1 | 1997 | 91 | 0.010 |
Why?
| | Linkage Disequilibrium | 1 | 1997 | 254 | 0.010 |
Why?
| | Pan troglodytes | 1 | 1997 | 65 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 1999 | 572 | 0.010 |
Why?
| | Hypoxia | 3 | 1973 | 1164 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 1997 | 309 | 0.010 |
Why?
| | Macaca mulatta | 1 | 1997 | 189 | 0.010 |
Why?
| | Gene Frequency | 1 | 1997 | 492 | 0.010 |
Why?
| | Haplotypes | 1 | 1997 | 499 | 0.010 |
Why?
| | Species Specificity | 1 | 1997 | 577 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 1997 | 352 | 0.010 |
Why?
| | Electric Impedance | 1 | 1996 | 112 | 0.010 |
Why?
| | Heart Conduction System | 2 | 1989 | 89 | 0.010 |
Why?
| | Erythrocytes | 1 | 2001 | 707 | 0.010 |
Why?
| | Stem Cells | 1 | 1999 | 603 | 0.010 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 1996 | 150 | 0.010 |
Why?
| | Dental Pulp Test | 1 | 1974 | 1 | 0.010 |
Why?
| | Alveolar Process | 1 | 1974 | 6 | 0.010 |
Why?
| | Tooth Mobility | 1 | 1974 | 5 | 0.010 |
Why?
| | Cell Movement | 1 | 1999 | 982 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 1997 | 624 | 0.010 |
Why?
| | Health Behavior | 1 | 2000 | 783 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1997 | 817 | 0.010 |
Why?
| | Equipment Design | 1 | 1996 | 525 | 0.010 |
Why?
| | Penis | 1 | 1993 | 34 | 0.010 |
Why?
| | New York City | 1 | 1993 | 87 | 0.010 |
Why?
| | Temperature | 1 | 1996 | 669 | 0.010 |
Why?
| | Nerve Endings | 1 | 1972 | 4 | 0.010 |
Why?
| | Rib Fractures | 1 | 1972 | 33 | 0.010 |
Why?
| | Baltimore | 1 | 1991 | 68 | 0.010 |
Why?
| | Mandibular Condyle | 1 | 1991 | 6 | 0.010 |
Why?
| | Connective Tissue | 1 | 1991 | 39 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1972 | 440 | 0.010 |
Why?
| | CD4 Antigens | 1 | 1991 | 141 | 0.010 |
Why?
| | Temporal Bone | 1 | 1991 | 43 | 0.010 |
Why?
| | Atrophy | 1 | 1991 | 196 | 0.010 |
Why?
| | Income | 1 | 1991 | 198 | 0.010 |
Why?
| | Chromatography, Affinity | 1 | 1990 | 86 | 0.010 |
Why?
| | Nitroprusside | 1 | 1990 | 72 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1990 | 130 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 335 | 0.000 |
Why?
| | Solubility | 1 | 1990 | 244 | 0.000 |
Why?
| | Immunoblotting | 1 | 1990 | 309 | 0.000 |
Why?
| | Disease Progression | 1 | 1997 | 2791 | 0.000 |
Why?
| | Syncope | 1 | 1989 | 57 | 0.000 |
Why?
| | Skin Diseases | 1 | 1990 | 148 | 0.000 |
Why?
| | Cardiac Pacing, Artificial | 1 | 1989 | 78 | 0.000 |
Why?
| | Enzyme Activation | 1 | 1990 | 801 | 0.000 |
Why?
| | Calcinosis | 1 | 1990 | 238 | 0.000 |
Why?
| | Cattle | 1 | 1990 | 991 | 0.000 |
Why?
| | Osteoporosis | 1 | 1990 | 242 | 0.000 |
Why?
| | Absenteeism | 1 | 1986 | 52 | 0.000 |
Why?
| | Psychotropic Drugs | 1 | 1986 | 74 | 0.000 |
Why?
| | Oral Surgical Procedures, Preprosthetic | 1 | 1985 | 1 | 0.000 |
Why?
| | Tooth Eruption | 1 | 1985 | 10 | 0.000 |
Why?
| | Malocclusion | 1 | 1985 | 24 | 0.000 |
Why?
| | Tooth Injuries | 1 | 1985 | 9 | 0.000 |
Why?
| | Periodontal Diseases | 1 | 1985 | 60 | 0.000 |
Why?
| | Asthma | 1 | 1996 | 1919 | 0.000 |
Why?
| | Heart Aneurysm | 1 | 1982 | 12 | 0.000 |
Why?
| | Ambulatory Care | 1 | 1986 | 584 | 0.000 |
Why?
| | Cryosurgery | 1 | 1982 | 47 | 0.000 |
Why?
| | Hypotension | 2 | 1972 | 122 | 0.000 |
Why?
| | Carbon Dioxide | 2 | 1973 | 241 | 0.000 |
Why?
| | Streptococcal Infections | 2 | 1973 | 151 | 0.000 |
Why?
| | Suicide | 1 | 1986 | 669 | 0.000 |
Why?
| | Respiration, Artificial | 2 | 1972 | 685 | 0.000 |
Why?
| | Rats | 1 | 1985 | 5594 | 0.000 |
Why?
| | Acid-Base Equilibrium | 1 | 1973 | 24 | 0.000 |
Why?
| | Neurologic Manifestations | 1 | 1972 | 3 | 0.000 |
Why?
| | Anuria | 1 | 1972 | 3 | 0.000 |
Why?
| | Drowning | 1 | 1972 | 6 | 0.000 |
Why?
| | Embolism, Fat | 1 | 1972 | 11 | 0.000 |
Why?
| | Positive-Pressure Respiration | 1 | 1973 | 107 | 0.000 |
Why?
| | Tracheotomy | 1 | 1972 | 25 | 0.000 |
Why?
| | Cyanosis | 1 | 1972 | 17 | 0.000 |
Why?
| | Mitral Valve Stenosis | 1 | 1972 | 19 | 0.000 |
Why?
| | Anti-Bacterial Agents | 2 | 1973 | 1856 | 0.000 |
Why?
| | Pneumococcal Infections | 1 | 1973 | 108 | 0.000 |
Why?
| | Blood Proteins | 1 | 1973 | 250 | 0.000 |
Why?
| | Shock | 1 | 1972 | 103 | 0.000 |
Why?
| | Heparin | 1 | 1972 | 258 | 0.000 |
Why?
| | Resuscitation | 1 | 1972 | 283 | 0.000 |
Why?
| | Hemorrhage | 1 | 1972 | 760 | 0.000 |
Why?
| | Pneumonia, Viral | 1 | 1972 | 371 | 0.000 |
Why?
| | Oxygen | 1 | 1972 | 992 | 0.000 |
Why?
| | Influenza, Human | 1 | 1973 | 625 | 0.000 |
Why?
| | Alcoholism | 1 | 1972 | 821 | 0.000 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|